Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Obstetrics and gynaecology indexChapter sections
Role and principlesAssessment and patient selectionBaseline assessmentInterventionsMedicines and treatment safetyTargets, monitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook10 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Contraception and debrief after complicated birth

Obstetrics and gynaecology · UK scope · Sources checked 7 Sept 2026 · Clinical review pending

RapidFull
!
A follow-up discussion may uncover urgent illness

Heavy bleeding, severe headache, breathlessness, suicidal intent or new psychotic symptoms reported during contraceptive or birth follow-up require immediate clinical attention.

Action: Pause the planned discussion, assess urgency and arrange emergency maternity, medical or mental health care as indicated; return to contraception and the birth review once immediate needs are addressed.

Role and principles

Offer timely contraceptive choices after birth while accounting for feeding, thrombotic risk and product timing, and provide a structured follow-up discussion after a complicated delivery.

Contraceptive counselling after a complicated birth has two linked aims: support the woman's reproductive choices and avoid leaving a gap while she recovers. Discuss options antenatally where possible and revisit them before discharge, checking whether preferences have changed. Effective contraception is needed from day twenty-one after birth when pregnancy is not desired. The absence of a period is not enough reassurance because ovulation can occur first. A routine six-to-eight-week review may be too late for the first discussion.

Begin with the woman's priorities rather than a default method. Ask whether she wants another pregnancy, how soon, whether daily tablets are realistic, which bleeding changes matter and whether she prefers a hormonal or non-hormonal option. Explain long-acting methods alongside shorter-acting choices and condoms, including the possibility of changing or removing a method later. After a traumatic event, additional procedures may feel unacceptable even when medically appropriate; an interim pill and a later appointment can be a reasonable agreed plan.

Assessment and patient selection

A contraception gap

A woman may have resumed sex while awaiting a routine review or an insertion appointment. Ask sensitively about intercourse since birth and whether any protection was used.

Changed medical eligibility

New VTE, ongoing high blood pressure, sepsis or interacting medicines may make a previously used method less suitable. Review current health rather than automatically restarting the pre-pregnancy prescription.

Lactational amenorrhoea criteria

LAM requires amenorrhoea, an infant younger than six months, and full or nearly full day-and-night breastfeeding without long gaps. Reduced feeding, menstruation or reaching six months requires another method.

Unresolved birth concerns

Distress, unanswered questions, avoidance of follow-up or fear of future pregnancy may become apparent during contraception counselling. Offer a separate discussion and assess mental health needs.

Red flags requiring action

  • New chest symptoms or unilateral swelling before considering an oestrogen-containing method.
  • Fever, pelvic tenderness or offensive discharge when intrauterine contraception is requested.
  • Suicidal thinking, marked confusion or unusual beliefs during discussion of the birth.
  • Persistent heavy bleeding or severe pain that has not been clinically assessed.

Baseline assessment

  1. 01
    Pregnancy risk assessmentFirst step
    Why
    Determine whether pregnancy can reasonably be excluded before initiation.
    Interpretation and limitations
    Consider timing of intercourse, current contraception, feeding and return of cycles. A negative urine test cannot exclude conception from very recent intercourse; arrange appropriate emergency contraception or follow-up testing.
  2. 02
    Blood pressure and medical eligibility review
    Why
    Identify conditions that alter contraceptive safety after birth.
    Interpretation and limitations
    Check current pressure before combined hormonal contraception and review UKMEC conditions. A history of pre-eclampsia with recovered pressure differs from ongoing severe hypertension.
  3. 03
    Targeted infection and genital assessment
    Why
    Evaluate symptoms or risks before intrauterine placement.
    Interpretation and limitations
    Use history, examination and STI assessment according to findings. Postpartum uterine sepsis requires treatment and deferral; routine contraception counselling does not require an intimate examination for every method.
  4. 04
    Birth record and outstanding results
    Why
    Prepare an accurate explanation and define unfinished clinical follow-up.
    Interpretation and limitations
    Review operative notes, haemorrhage records, investigations and specialist recommendations before the meeting. Distinguish documented facts from interpretations and identify questions that require further review.

Interventions

01Before dischargeProvide an agreed method or a bridgeFirst stepThe woman wishes to avoid pregnancy during recovery after birth.+
  1. 1Discuss preferences and check postpartum eligibility, feeding plans and relevant medication interactions.
  2. 2Provide the selected method when feasible or prescribe an acceptable interim option with a definite later appointment.
  3. 3Explain when protection starts, any need for condoms or abstinence, and how to obtain help for adverse effects or a change of preference.
02Later presentationAssess recent intercourse before starting contraceptionContraception is requested on or after day twenty-one postpartum.+
  1. 1Establish intercourse dates and whether LAM or another method has provided reliable protection.
  2. 2Consider oral emergency contraception from day twenty-one and a copper IUD for emergency contraception from day twenty-eight when appropriate to timing and eligibility.

Medicines and treatment safety

Provides an oestrogen-free daily option or temporary contraception while another method is arranged.

Desogestrel progestogen-only pill

Take 75 micrograms orally once daily continuously without a pill-free interval. FSRH supports immediate postpartum initiation; if quick-started on or after day 21 without valid LAM protection, use additional precautions for 2 days.

Assess pregnancy risk, breast cancer history, unexplained bleeding and enzyme-inducing medicines. Product labels may differ from FSRH initiation advice; document the chosen guidance and teach the specific missed-pill rules.

Offers long-acting reversible contraception without reliance on daily tablet-taking.

Nexplanon etonogestrel implant

Insert one 68 mg implant subdermally by a trained practitioner; the current UK licence allows 5 years. Immediate postpartum insertion is permitted after individual assessment; insertion after day 21 requires 7 days of barrier protection.

Exclude pregnancy as required, review contraindications and enzyme-inducing drugs, and confirm palpability after insertion. Give an alert card and review advice for non-palpability, troublesome bleeding or a request for removal.

Provides long-term contraception and may reduce menstrual bleeding once established.

Mirena levonorgestrel intrauterine system

Insert one 52 mg intrauterine system by a trained clinician; contraceptive use is licensed for 8 years. Its postpartum label specifies complete involution and at least 6 weeks after delivery; FSRH-supported earlier insertion requires documented off-label counselling.

Targets, monitoring and follow-up

  • Confirm that a bridging prescription and the intended long-acting method appointment remain accessible, particularly after readmission or changes in infant care.
  • Check troublesome bleeding or pain rather than assuming it is solely a contraceptive effect when postpartum infection or haemorrhage remains possible.
  • Review adherence and the exact pill formulation when missed doses occur; traditional, desogestrel and drospirenone pills have different instructions.
  • After a complicated birth, check whether the woman received results and referrals and whether the explanation addressed her original questions.
  • Revisit feeding and reproductive preferences over time, since changes may alter LAM reliability or the acceptability of the current method.

Special situations

Different pill precaution intervals

When additional precautions are required after postpartum initiation, FSRH uses two days for traditional or desogestrel POP and seven days for drospirenone POP. The drospirenone schedule must not inherit desogestrel instructions.

Injectable progestogen and VTE risk

UKMEC 2025 classifies early postpartum DMPA with additional thrombotic risks as category three, meaning it is generally unsuitable without expert judgement. An implant or POP may have a more favourable eligibility category.

Breastfeeding is a changing exposure

LAM depends on continued feeding patterns as well as amenorrhoea and infant age. Long intervals, supplementation or reduced night feeds should prompt discussion of another method before protection is assumed.

Debrief at the woman's pace

Some women want a detailed clinical explanation quickly, while others prefer a later meeting. Offering choice and answering specific questions can support understanding without making disclosure or emotional processing compulsory.

Common pitfalls

  1. 01

    Waiting for the first period or a six-week appointment can leave a preventable contraception gap.

  2. 02

    Treating every progestogen-only method as equally suitable overlooks current early postpartum DMPA restrictions.

  3. 03

    Quoting a device duration from an older leaflet can give incorrect replacement advice after a licence update.

  4. 04

    Providing a confident explanation without checking the birth record can compound distress when later information conflicts.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Obstetrics and gynaecologyOriginal SBA

Interval intrauterine contraception timing

A woman is ten days postpartum after an uncomplicated birth, has no infection and wants intrauterine contraception. The immediate insertion window has passed. Under FSRH professional guidance, from when can interval insertion generally be arranged?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Obstetrics and gynaecology topics →
Sources and review status8 sources · checked 7 Sept 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

  • FSRH contraception after pregnancy guideline
  • CoSRH UKMEC 2025 contraceptive eligibility tables
  • FSRH progestogen-only pills amended April 2026
  • FSRH intrauterine contraception clinical guideline
  • Nexplanon current UK summary of product characteristics
  • Mirena current UK summary of product characteristics
  • NICE NG194 postnatal care recommendations
  • NICE CG192 antenatal and postnatal mental health recommendations

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem ·

Reassess medical eligibility using the current UKMEC and the complications that actually occurred. VTE, persistent hypertension, migraine with aura, smoking, obesity, sepsis and relevant medicines can alter choices. Combined hormonal contraception is unsuitable during the first six weeks of breastfeeding and is generally avoided in the earliest postpartum weeks because of thrombosis risk. A non-breastfeeding woman without additional VTE risks may be eligible from three weeks, but other contraindications still apply. Reaching a calendar date does not erase a new thrombotic diagnosis.

Progestogen-only methods are not identical. Pills and implants can generally be started immediately postpartum, including during breastfeeding, after individual assessment. UKMEC 2025 treats depot medroxyprogesterone acetate more cautiously in the early postpartum period when additional VTE risks exist; it is category three in the first six weeks in that setting. Do not group all progestogen methods together when a woman has just had surgery, substantial immobility or other thrombotic risks.

Intrauterine contraception can be inserted by an appropriately trained clinician within forty-eight hours of birth, or generally from four weeks under FSRH guidance. If that early window has passed, arrange an interim method. Postpartum sepsis is a contraindication to insertion, and active unexplained bleeding or other concerns need assessment. Immediate insertion has a higher expulsion risk than interval insertion, while breastfeeding and recent birth increase perforation risk at interval placement; explain the absolute clinical context without making the method sound uniformly unsafe.

Specific product information must also be checked. The current UK Nexplanon licence permits five years of use and immediate postpartum insertion after an individual benefit–risk assessment. Mirena's label specifies postpartum insertion after uterine involution and no earlier than six weeks, whereas FSRH supports appropriately provided insertion from four weeks and immediate postpartum practice. Where professional recommendations support use outside the licence, explain and document that decision with the woman's informed agreement. Do not mix one product's duration with another device's indication.

A post-birth discussion is an opportunity to understand the woman's experience and connect it with the clinical record. Invite her questions before narrating the sequence of events. Explain what was observed, why interventions were recommended, what is known about the outcome and what remains uncertain. Acknowledge distress and gaps in memory without forcing a detailed retelling. Offer another meeting when she is ready, and include a partner or support person if she wishes.

The practical output should be a shared recovery plan. Clarify outstanding results, wound or pelvic-floor follow-up, blood pressure checks, anaemia treatment, anticoagulation and mental health support as relevant. Discuss implications for a future pregnancy, including the need for a specialist preconception review after major complications. A factual birth review is different from compulsory psychological debriefing: persistent traumatic stress needs assessment and evidence-based psychological care, and not everyone benefits from recounting the event immediately.

Key points

  • Discuss contraception before discharge and ensure protection is planned by day twenty-one.
  • Ovulation can occur before the first menstrual bleed returns.
  • Breastfeeding provides reliable contraception only when all lactational amenorrhoea criteria apply.
  • Early postpartum eligibility differs between implants, pills and injectable progestogens.
  • Professional insertion guidance and a specific device licence may use different timings.
  • A birth discussion should answer the woman's questions and produce an actionable follow-up plan.
  • 3Quick-start an eligible method under the relevant guidance, specifying additional precautions and a pregnancy test twenty-one days after the last unprotected intercourse when required.
    • 03Device requestApply insertion timing and product informationThe woman requests an implant or intrauterine contraceptive after delivery.+
    1. 1Check the exact device, trained insertion availability and any condition such as uterine sepsis that changes suitability.
    2. 2For IUC after the first forty-eight hours, arrange insertion from four weeks under FSRH guidance, explaining any difference from the chosen product licence.
    3. 3Document duration, follow-up advice, expulsion or non-palpable implant concerns, and an accessible route for removal or review.
    04Birth reviewTurn explanation into a recovery planThe woman requests discussion or has unresolved concerns after a complicated birth.+
    1. 1PreferredAsk which questions matter most and review the clinical record with her preferred support person present if desired.
    2. 2Explain decisions, outcomes and uncertainties clearly, allowing pauses and avoiding pressure to relive distressing details.
    3. 3Agree responsibility for outstanding results, recovery referrals and future pregnancy advice, offering another contact if questions arise later.

    Do not insert with postpartum sepsis or before assessing unexplained concerning bleeding. Discuss expulsion and perforation, check pregnancy exclusion and additional precautions, and distinguish contraceptive duration from other therapeutic indications.

    Content changes
    Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom